Sangamo Therapeutics (SGMO) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free SGMO Stock Alerts $0.56 +0.03 (+5.71%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Sangamo Therapeutics Short Interest DataCurrent Short Volume13,250,000 sharesPrevious Short Volume11,410,000 sharesChange Vs. Previous Month+16.13%Dollar Volume Sold Short$7.36 millionShort Interest Ratio / Days to Cover5.6Last Record DateApril 15, 2024Outstanding Shares207,500,000 sharesPercentage of Shares Shorted6.39%Today's Trading Volume1,184,796 sharesAverage Trading Volume1,348,226 sharesToday's Volume Vs. Average88% Short Selling Sangamo Therapeutics ? Sign up to receive the latest short interest report for Sangamo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSGMO Short Interest Over TimeSGMO Days to Cover Over TimeSGMO Percentage of Float Shorted Over Time Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. Sangamo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202413,250,000 shares $7.36 million +16.1%N/A5.6 $0.56 3/31/202411,410,000 shares $7.65 million +4.9%N/A4.9 $0.67 3/15/202410,880,000 shares $8.49 million +8.2%N/A4.6 $0.78 2/29/202410,060,000 shares $11.67 million +3.4%N/A4.7 $1.16 2/15/20249,730,000 shares $10.22 million -2.5%N/A4.8 $1.05 1/31/20249,980,000 shares $4.56 million +9.0%N/A6 $0.46 Get the Latest News and Ratings for SGMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sangamo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20249,160,000 shares $4.72 million +0.2%N/A5.5 $0.52 12/31/20239,140,000 shares $4.97 million -0.8%N/A4.9 $0.54 12/15/20239,210,000 shares $3.82 million -4.9%N/A4.3 $0.42 11/30/20239,680,000 shares $4.16 million -6.1%N/A4.7 $0.43 11/15/202310,310,000 shares $3.77 million -11.0%N/A4.9 $0.37 10/31/202311,590,000 shares $7.30 million +10.4%N/A6.1 $0.63 10/15/202310,500,000 shares $5.88 million +15.3%N/A5.9 $0.56 9/30/20239,110,000 shares $5.46 million -5.2%N/A4.9 $0.60 9/15/20239,610,000 shares $9.60 million -8.1%N/A6.3 $1.00 8/31/202310,460,000 shares $10.14 million -2.5%N/A5.5 $0.97 8/15/202310,730,000 shares $10.84 million -1.5%N/A5.1 $1.01 7/31/202310,890,000 shares $14.32 million -5.2%N/A4.7 $1.32 7/15/202311,490,000 shares $14.82 million -4.0%N/A4.6 $1.29 6/30/202311,970,000 shares $15.56 million -19.2%N/A4.7 $1.30 6/15/202314,820,000 shares $17.19 million +1.9%N/A5.6 $1.16 5/31/202314,540,000 shares $16.28 million -17.4%N/A6.3 $1.12 5/15/202317,610,000 shares $23.60 million -12.9%N/A7.5 $1.34 4/30/202320,220,000 shares $29.72 million +3.8%14.1%9.5 $1.47 4/15/202319,490,000 shares $32.16 million +4.4%13.6%10 $1.65 3/31/202318,670,000 shares $32.86 million +13.8%14.2%10.5 $1.76 3/15/202316,410,000 shares $35.45 million +38.1%12.5%10.1 $2.16 2/28/202311,880,000 shares $36.23 million +2.2%9.0%7.8 $3.05 2/15/202311,620,000 shares $34.86 million -2.5%9.1%8.6 $3.00 1/31/202311,920,000 shares $41.60 million -0.8%9.3%8.8 $3.49 1/15/202312,010,000 shares $43.72 million -2.8%9.4%8.7 $3.64 12/30/202212,360,000 shares $38.81 million +11.0%9.6%9 $3.14 12/15/202211,140,000 shares $36.76 million -1.2%8.7%8.1 $3.30 11/30/202211,270,000 shares $41.25 million -0.7%8.9%8.3 $3.66 11/15/202211,350,000 shares $44.38 million -6.5%9.0%8 $3.91 10/31/202212,140,000 shares $53.29 million +1.3%8.8%8.4 $4.39 10/15/202211,980,000 shares $55.47 million +9.4%9.1%8.3 $4.63 9/30/202210,950,000 shares $53.66 million +17.5%8.3%7.4 $4.90 9/15/20229,320,000 shares $54.06 million +5.6%7.1%6.1 $5.80 8/31/20228,830,000 shares $47.68 million -6.8%6.8%5.5 $5.40Investors Alert: The Next Big Thing in Weight Loss (Ad)UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> SGMO Short Interest - Frequently Asked Questions What is Sangamo Therapeutics' current short interest? Short interest is the volume of Sangamo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 13,250,000 shares of SGMO short. Learn More on Sangamo Therapeutics' current short interest. What is a good short interest ratio for Sangamo Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SGMO shares currently have a short interest ratio of 6.0. Learn More on Sangamo Therapeutics's short interest ratio. Is Sangamo Therapeutics' short interest increasing or decreasing? Sangamo Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 13,250,000 shares, an increase of 16.1% from the previous total of 11,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sangamo Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sangamo Therapeutics: Curis, Inc. (1.01%), SAB Biotherapeutics, Inc. (0.34%), Agenus Inc. (13.01%), aTyr Pharma, Inc. (0.56%), BioAtla, Inc. (11.27%), Vigil Neuroscience, Inc. (6.18%), Outlook Therapeutics, Inc. (7.41%), bluebird bio, Inc. (29.83%), AlloVir, Inc. (5.57%), Omega Therapeutics, Inc. (21.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Sangamo Therapeutics stock? Short selling SGMO is an investing strategy that aims to generate trading profit from Sangamo Therapeutics as its price is falling. SGMO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sangamo Therapeutics? A short squeeze for Sangamo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SGMO, which in turn drives the price of the stock up even further. How often is Sangamo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGMO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Curis Short Interest SAB Biotherapeutics Short Interest Agenus Short Interest aTyr Pharma Short Interest BioAtla Short Interest Vigil Neuroscience Short Interest Outlook Therapeutics Short Interest bluebird bio Short Interest AlloVir Short Interest Omega Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SGMO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith